Butterfly Medical Announces Completion of Pivotal Trial for Minimally Invasive Treatment of Benign Prostatic Hyperplasia

The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
MassDevice

Butterfly Medical completes clinical trial of BPH treatment device

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...
NBC4 Columbus

New Data Highlighting Effectiveness of Butterfly Medical's Minimally Invasive Device for Benign Prostatic Hyperplasia (BPH) Treatment to Be Presented at AUA 2025

BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced ...
abc27

Butterfly Medical Appoints Chief Medical Officer To Advance Novel Treatment for Benign Prostatic Hyperplasia

Cleveland Clinic Urologist Dr. James Ulchaker will Support Efforts Toward FDA Approval and U.S. Commercialization While Contributing to Medical Strategy and Patient-Focused Care BPH affects up to 50 ...